224 related articles for article (PubMed ID: 20104011)
1. [Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment : a case report].
Segawa N; Inamoto T; Ibuki N; Mizutani Y; Azuma H; Tsuji M; Katsuoka Y
Hinyokika Kiyo; 2010 Jan; 56(1):49-54. PubMed ID: 20104011
[TBL] [Abstract][Full Text] [Related]
2. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
3. [Small cell carcinoma of the prostate: a case report].
Sakai H; Tsuruta T; Wajiki M
Hinyokika Kiyo; 2004 Apr; 50(4):269-71. PubMed ID: 15188622
[TBL] [Abstract][Full Text] [Related]
4. [Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].
Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K
Hinyokika Kiyo; 2007 Jul; 53(7):489-92. PubMed ID: 17702184
[TBL] [Abstract][Full Text] [Related]
5. [Small cell carcinoma of the prostate: a case report].
Hashine K; Nakatsuji H; Karashima T; Sumiyoshi Y; Mandai K; Hata A
Hinyokika Kiyo; 1998 Aug; 44(8):607-10. PubMed ID: 9783201
[TBL] [Abstract][Full Text] [Related]
6. [Small cell carcinoma of the prostate: a case report].
Yamamoto N; Kinoshita H; Inoue T; Kawakita S; Oguchi N; Muguruma K; Kawa G; Sakaguchi Y; Adachi Y; Sakaida N; Uemura Y; Matsuda T
Hinyokika Kiyo; 2007 Sep; 53(9):665-9. PubMed ID: 17933147
[TBL] [Abstract][Full Text] [Related]
7. [A case of huge prostate cancer].
Miyajima A; Ikeuchi K
Hinyokika Kiyo; 1995 Sep; 41(9):683-5. PubMed ID: 7484533
[TBL] [Abstract][Full Text] [Related]
8. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
Miller N; Smolkin ME; Bissonette E; Theodorescu D
Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
[TBL] [Abstract][Full Text] [Related]
9. [Small cell carcinoma of the prostate: a case report].
Tsukino H; Nagano M; Takehara T; Hamasuna R; Hasui Y; Osada Y
Hinyokika Kiyo; 2001 Feb; 47(2):113-6. PubMed ID: 11280883
[TBL] [Abstract][Full Text] [Related]
10. [Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment: a case report].
Matsumoto Y; Mibu H; Kagebayashi Y
Hinyokika Kiyo; 2004 Nov; 50(11):813-5. PubMed ID: 15628545
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant hormonal therapy in stage C adenocarcinoma of the prostate.
Andros EA; Danesghari F; Crawford ED
Clin Invest Med; 1993 Dec; 16(6):510-5. PubMed ID: 7516835
[TBL] [Abstract][Full Text] [Related]
12. [A case of poorly differentiated adenocarcinoma of prostate with neuroendocrine differentiation].
Miyoshi Y; Inoue Y; Matsuzaki J; Fukuda M; Satomi Y; Akahane H; Saito S
Hinyokika Kiyo; 1998 Feb; 44(2):113-6. PubMed ID: 9546133
[TBL] [Abstract][Full Text] [Related]
13. [A case of giant small cell carcinoma of the prostate].
Yashi M; Suzuki K; Tokue A
Hinyokika Kiyo; 2001 Jan; 47(1):55-7. PubMed ID: 11235225
[TBL] [Abstract][Full Text] [Related]
14. Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer.
Fair WR; Betancourt JE
Mol Urol; 2000; 4(3):241-8;discussion 249-50. PubMed ID: 11062380
[TBL] [Abstract][Full Text] [Related]
15. [Prostate small cell carcinoma: report of two cases that differed in treatment responsiveness].
Yoshida T; Nishimura K; Uemura M; Nakagawa K; Harada Y; Kanno N; Miyoshi S; Kawano K
Hinyokika Kiyo; 2006 Nov; 52(11):891-4. PubMed ID: 17176877
[TBL] [Abstract][Full Text] [Related]
16. [Prostatic cancer with cystic formation: a case report].
Takayama H; Arai Y; Meguro N; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
Hinyokika Kiyo; 1996 Dec; 42(12):977-80. PubMed ID: 9013236
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine differentiation of localized prostate cancer during endocrine therapy.
Nemoto K; Tomita Y
Scand J Urol Nephrol; 2007; 41(6):558-60. PubMed ID: 17853028
[TBL] [Abstract][Full Text] [Related]
18. [Estramustine phosphate withdrawal syndrome in relapsed prostate cancer: two case reports].
Kobayashi S; Tsukamoto T; Tohsaka A; Tohma T
Hinyokika Kiyo; 2008 Jun; 54(6):423-6. PubMed ID: 18634439
[TBL] [Abstract][Full Text] [Related]
19. Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.
Scholz M; Lam R; Strum S; Jennrich R; Johnson H; Trilling T
Urology; 2007 Sep; 70(3):506-10. PubMed ID: 17905106
[TBL] [Abstract][Full Text] [Related]
20. [Giant prostate carcinoma treated effectively with endocrine therapy: case report].
Masue N; Hasegawa Y
Hinyokika Kiyo; 2007 Feb; 53(2):133-5. PubMed ID: 17352166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]